Global Dialysis - Firms race to develop renal denervation catheters to treat hypertension.

Firms race to develop renal denervation catheters to treat hypertension.

Star Tribune: This month, St. Jude Medical announced that its EnligHTN renal denervation system safely and effectively lowered blood pressure at six months. Boston Scientific also announced it will pay as much as $425 million for a California company that has developed a renal denervation system that has been approved for use in Europe and Australia. Medtronic's Symplicity system is on its third trial overall, first in the U.S., and has won European and Australian market approval. It has been used on more than 4,000 patients.

...